Melanoma: Adjuvant treatment of patients with Stage IIB, IIC, or III melanoma following complete resection

1 total trials

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Assessment of Pharmacokinetic Similarity of FYB206 in Comparison with Keytruda in Resected Stage II or Stage III Melanoma Patients Recruitment ended

2023-509765-20-00 2 2024-10-21

Showing 1–1 of 1 trials